PM14 Administered Intravenously to Patients With Advanced Solid Tumors

Summary

Despite recent advances in the treatment of solid tumors in general, advanced (metastatic) disease remains mostly incurable and there is an urgent need to develop new therapeutic options for these patients, particularly investigational drugs with novel mechanisms of action. The investigation of new combination regimens of non-crossresistant agents with acceptable-and not completely overlapping-toxicities has been a major way to improve response rate and outcome of patients with advanced solid tumors.

Timeline

Start

2017-09-06

Primary completion

2025-08-21

Completion

2025-08-21

Drugs

Indications